ValitaCell Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Investors
-
2
ValitaCell General Information
Description
Provider of biotechnology services intended to improve the efficiency and performance of cell development. The company's biotechnology services include antibody titer, fluorescence polarisation, and clone selection to treat diseases such as cancer, cardiovascular disease, and a number of rare illnesses, enabling clients to bring innovative medicines to the market faster, cheaper, and with greater regulatory confidence.
Contact Information
Website
www.valitacell.comCorporate Office
- NIBRT, Fosters Avenue
- Mount Merrion, Blackrock
- Dublin A94 X099
- Ireland
Corporate Office
- NIBRT, Fosters Avenue
- Mount Merrion, Blackrock
- Dublin A94 X099
- Ireland
ValitaCell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 13-Sep-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 19-Mar-2021 | Completed | Generating Revenue | |||
| 4. Grant | 15-Jun-2017 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 05-Dec-2016 | Completed | Generating Revenue | |||
| 2. Grant | 24-Nov-2016 | $130K | $1.46M | Completed | Generating Revenue | |
| 1. Angel (individual) | 30-Aug-2016 | $1.46M | $1.46M | Completed | Generating Revenue |
ValitaCell Patents
ValitaCell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4634828-A1 | A method for evaluating trust of convolutional neural network outputs | Active | 12-Dec-2022 | ||
| EP-4634828-B1 | A method for evaluating trust of convolutional neural network outputs | Active | 12-Dec-2022 | ||
| EP-4634828-C0 | A method for evaluating trust of convolutional neural network outputs | Active | 12-Dec-2022 | ||
| US-20260203557-A1 | A method for evaluating trust of convolutional neural network outputs | Pending | 12-Dec-2022 | ||
| WO-2024126531-A1 | A method for evaluating trust of convolutional neural network outputs | Inactive | 12-Dec-2022 | G06N3/0464 |
ValitaCell Signals
ValitaCell Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enterprise Ireland | Growth/Expansion | Minority | ||
| Angel (individual) | Minority | |||
| Plug and Play | Accelerator/Incubator | Minority | ||
| Startup Creasphere | Accelerator/Incubator | Minority |
ValitaCell FAQs
-
When was ValitaCell founded?
ValitaCell was founded in 2014.
-
Where is ValitaCell headquartered?
ValitaCell is headquartered in Dublin, Ireland.
-
What is the size of ValitaCell?
ValitaCell has 20 total employees.
-
What industry is ValitaCell in?
ValitaCell’s primary industry is Discovery Tools (Healthcare).
-
Is ValitaCell a private or public company?
ValitaCell is a Private company.
-
What is ValitaCell’s current revenue?
The current revenue for ValitaCell is .
-
How much funding has ValitaCell raised over time?
ValitaCell has raised $3.1M.
-
Who are ValitaCell’s investors?
Enterprise Ireland, , Plug and Play, and Startup Creasphere have invested in ValitaCell.
-
When was ValitaCell acquired?
ValitaCell was acquired on 13-Sep-2022.
-
Who acquired ValitaCell?
ValitaCell was acquired by Beckman Coulter.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process